Related Experiment Video
Updated: Jan 7, 2026

Laparoscopic Repair of Para-Esophageal Hernia Using Absorbable Biosynthetic Mesh
Published on: September 11, 2021
Post-esophagectomy hiatal hernias: a systematic review and meta-analysis
Evgenia Mela1, Ioannis Katsaros2, Adam Mylonakis1
1First Department of Surgery, National and Kapodistrian University of Athens, Laikon General Hospital, 17 Agiou Thoma Str., 11527, Athens, Greece.
Post-esophagectomy hiatal hernia (PEHH) is increasingly reported, especially after minimally invasive esophagectomy (MIE). Obesity may be protective, while neoadjuvant therapy increases risk, necessitating individualized treatment strategies.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Medical Statistics
Background:
- Post-esophagectomy hiatal hernia (PEHH) is a rare but serious complication.
- Minimally invasive esophagectomy (MIE) approaches may increase PEHH risk.
- Understanding PEHH incidence and risk factors is crucial for patient management.
Purpose of the Study:
- To systematically review and meta-analyze the incidence, risk factors, diagnostics, and treatments for PEHH.
- To identify factors associated with PEHH development after esophagectomy.
- To evaluate outcomes of surgical repair for PEHH.
Main Methods:
- Systematic literature search of MEDLINE, Scopus, and Cochrane databases (PRISMA guidelines).
- Meta-analysis of 34 studies including 837 PEHH cases to determine pooled odds ratios (ORs).
- Assessment of risk factors including MIE, obesity, and neoadjuvant chemoradiotherapy.
Main Results:
- Overall PEHH incidence was 4.1%.
- MIE (OR: 5.70) and neoadjuvant chemoradiotherapy (OR: 3.53) were associated with increased PEHH risk.
- Obesity (BMI > 25 kg/m²) significantly reduced PEHH rates (OR: 0.84).
- Minimally invasive repair was used in 50.4% of cases, with 31.7% morbidity and 2.1% mortality.
Conclusions:
- PEHH incidence is rising, with MIE and neoadjuvant therapy as significant risk factors.
- Surgical repair is standard for symptomatic PEHH.
- An individualized approach is recommended for asymptomatic PEHH, considering cancer prognosis.
Related Concept Videos
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Esophageal Varices-I: Introduction

